Legalize59765 laws
59765 laws
- § 337. Proceedings in name of United States; provision as to subpoenas
- § 337a. Extraterritorial jurisdiction
- § 341. Definitions and standards for food
- § 342. Adulterated food
- § 343. Misbranded food
- § 347b. Contravention of State laws
- § 348. Food additives
- § 349. Bottled drinking water standards; publication in Federal Register
- § 350. Vitamins and minerals
- § 350a. Infant formulas
- § 350a–1. Protecting infants and improving formula supply
- § 350b. New dietary ingredients
- § 350c. Maintenance and inspection of records
- § 350d. Registration of food facilities
- § 350f. Reportable food registry
- § 355. New drugs
- § 355a. Pediatric studies of drugs
- § 355c. Research into pediatric uses for drugs and biological products
- § 355c–1. Report
- § 355d. Internal committee for review of pediatric plans, assessments, deferrals, deferral extensions, and waivers
- § 355f. Extension of exclusivity period for new qualified infectious disease products
- § 355g. Utilizing real world evidence
- § 355h. Regulation of certain nonprescription drugs that are marketed without an approved drug application
- § 1480. Repealed. [Pub. L. 89–554, § 8(a)](/us/pl/89/554/s8/a), Sept. 6, 1966, [80 Stat. 657](/us/stat/80/657), 658
- § 356g. Standards for regenerative medicine and regenerative advanced therapies
- § 356h. Competitive generic therapies
- § 356j. Discontinuance or interruption in the production of medical devices
- § 356l. Advanced manufacturing technologies designation program
- § 356–1. Accelerated approval of priority countermeasures
- § 356–2. Accelerated approval Council
- § 357. Qualification of drug development tools
- § 358. Authority to designate official names
- § 359. Nonapplicability of subchapter to cosmetics
- § 360. Registration of producers of drugs or devices
- § 360bbb–1. Dispute resolution
- § 360bbb–2. Classification of products
- § 360bbb–3. Authorization for medical products for use in emergencies
- § 360bbb–3a. Emergency use of medical products
- § 360bbb–3b. Products held for emergency use
- § 360bbb–3c. Expedited development and review of medical products for emergency uses
- § 360bbb–4. Countermeasure development, review, and technical assistance
- § 360bbb–4a. Priority review to encourage treatments for agents that present national security threats
- § 360bbb–4b. Medical countermeasure master files
- § 360d. Performance standards
- § 360dd. Open protocols for investigations of drugs for rare diseases or conditions
- § 360ddd. Definitions
- § 360ddd–1. Regulation of medical gases
- § 360ddd–2. Inapplicability of drug fees to designated medical gases
- § 360e. Premarket approval
- §§ 1503 to 1505. Repealed. [Aug. 26, 1954, ch. 937](/us/act/1954-08-26/ch937), title V, § 542(a)(4), (10), [68 Stat. 861](/us/stat/68/861)